$JNCE Jounce Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jounce Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Jounce Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Jounce Therapeutics, Inc. for free.
IRS Number: 454870634
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: JNCE
Company Address: 780 MEMORIAL DRIVE CAMBRIDGE 02139
Phone number: 857-259-3840
Market Capitalization: $140.99M
Prev close: $17.30
Average Daily Volume: 711,175
Days Low: $17.19
Year Low: $16.33
Year High: $18.50
Jounce Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,500,000 | 0 | 4,447,829 | 5.9 M to 4.4 M (-25.22 %) |
| Apr 16 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 10.00 | 200 | 2,000 | 9,713 | 9.9 K to 9.7 K (-2.02 %) |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Option Exercise | M | 4.02 | 8,300 | 33,366 | 203,885 | |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Option Exercise | M | 4.02 | 100 | 402 | 212,185 | |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Option Exercise | M | 4.02 | 5,100 | 20,502 | 212,285 | |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Sell | S | 10.09 | 8,300 | 83,747 | 93,585 | 101.9 K to 93.6 K (-8.15 %) |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Buy | M | 4.02 | 8,300 | 33,366 | 101,885 | 93.6 K to 101.9 K (+8.87 %) |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Sell | S | 10.00 | 100 | 1,000 | 93,585 | 93.7 K to 93.6 K (-0.11 %) |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Buy | M | 4.02 | 100 | 402 | 93,685 | 93.6 K to 93.7 K (+0.11 %) |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Sell | S | 10.09 | 5,100 | 51,459 | 93,585 | 98.7 K to 93.6 K (-5.17 %) |
| Mar 31 2021 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Buy | M | 4.02 | 5,100 | 20,502 | 98,685 | 93.6 K to 98.7 K (+5.45 %) |
| Mar 17 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 12.80 | 200 | 2,560 | 9,913 | 10.1 K to 9.9 K (-1.98 %) |
| Mar 15 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,250,000 | 0 | 6,500,349 | 7.8 M to 6.5 M (-16.13 %) |
| Feb 18 2021 | JNCE | Jounce Therapeutic ... | Higgons John Duncan | Director | Sell | S | 11.78 | 200 | 2,356 | 10,113 | 10.3 K to 10.1 K (-1.94 %) |
| Feb 12 2021 | JNCE | Jounce Therapeutic ... | Salter-Cid Luisa | Director | Option Exercise | A | 12.36 | 31,400 | 388,104 | 31,400 |